E

Intelligent Bio Solutions Inc. INBS

$1.70 -$0.01-0.59% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
Access our Premium Ratings
Get Access

Rating

Reward
Risk

Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

Company Overview

Intelligent Bio Solutions Inc. is a medical technology and diagnostics company focused on non-invasive drug screening and biosensor-based testing solutions. The company operates primarily in the workplace safety, healthcare screening, and compliance monitoring sectors, with a commercial emphasis on rapid testing technologies designed to replace or supplement traditional saliva, urine, and blood-based testing methods. Its core commercial platform is the Intelligent Fingerprinting Drug Screening System, which uses fingerprint sweat analysis to detect recent drug use without the need for invasive sample collection.

The company’s principal revenue driver is the sale and deployment of its fingerprint-based drug testing system, including portable readers, consumable test cartridges, and associated screening services. Intelligent Bio Solutions evolved from earlier biosensor and life sciences initiatives and has repositioned its strategy around commercializing rapid diagnostics and workplace screening technologies. Public filings indicate that the company has focused on regulated screening environments where speed, portability, and hygiene are operational advantages, particularly in transportation, manufacturing, logistics, and safety-sensitive industries.

Data compiled by narrative technology. May contain errors.
Sector

Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

Filings

Filing Date
Wednesday, August 19, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)

Price History

Loading...
52-Week Range1% of range
Low
$1.52
Current
$1.70
High
$24.90
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High

Valuation

Market Cap
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

Corporate Info

Website
Phone Number
646 828 8258
Address
135 West, 41st Street
5th Floor
New York, NY 10036
Country
Year Founded

Headlines